Kotra Industries Berhad First Quarter 2023 Earnings: EPS: RM0.12 (vs RM0.10 in 1Q 2022)




  • In Business
  • 2022-12-04 01:20:25Z
  • By Simply Wall St.
 

Kotra Industries Berhad (KLSE:KOTRA) First Quarter 2023 Results

Key Financial Results

  • Revenue: RM64.8m (up 27% from 1Q 2022).

  • Net income: RM18.2m (up 22% from 1Q 2022).

  • Profit margin: 28% (down from 29% in 1Q 2022). The decrease in margin was driven by higher expenses.

  • EPS: RM0.12 (up from RM0.10 in 1Q 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Kotra Industries Berhad Earnings Insights

Looking ahead, revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Asia.

Performance of the market in Malaysia.

The company's shares are up 6.3% from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Kotra Industries Berhad that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You'll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

COMMENTS

More Related News

TAT Technologies (NASDAQ:TATT) shareholders have endured a 41% loss from investing in the stock five years ago
TAT Technologies (NASDAQ:TATT) shareholders have endured a 41% loss from investing in the stock five years ago

TAT Technologies Ltd. ( NASDAQ:TATT ) shareholders should be happy to see the share price up 12% in the last month. But...

Investing in Intapp (NASDAQ:INTA) a year ago would have delivered you a 53% gain
Investing in Intapp (NASDAQ:INTA) a year ago would have delivered you a 53% gain

The simplest way to invest in stocks is to buy exchange traded funds. But investors can boost returns by picking...

Investors in Bicycle Therapeutics (NASDAQ:BCYC) have made a impressive return of 157% over the past three years
Investors in Bicycle Therapeutics (NASDAQ:BCYC) have made a impressive return of 157% over the past three years

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...

Investors in Confluent (NASDAQ:CFLT) from a year ago are still down 63%, even after 9.5% gain this past week
Investors in Confluent (NASDAQ:CFLT) from a year ago are still down 63%, even after 9.5% gain this past week

Even the best stock pickers will make plenty of bad investments. Anyone who held Confluent, Inc. ( NASDAQ:CFLT ) over...

Guardant Health (NASDAQ:GH) investors are sitting on a loss of 59% if they invested three years ago
Guardant Health (NASDAQ:GH) investors are sitting on a loss of 59% if they invested three years ago

Guardant Health, Inc. ( NASDAQ:GH ) shareholders should be happy to see the share price up 16% in the last month. But...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business